Related Experiment Videos
Prion protein interactions with nucleic acid: possible models for prion disease and prion function
Abraham Grossman1, Brian Zeiler, Victor Sapirstein
1Q-RNA, Inc., 3960 Broadway, Suite 407, New York, New York 10032, USA. grossman@q-rna.com
Neurochemical Research
|April 30, 2003
Summary
Nucleic acids (NAs) may act as catalysts or chaperones in prion disease transmission. They appear to induce the cellular prion protein (PrP(c)) to adopt the disease-associated PrP(Sc) structure, influencing disease progression.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Prion diseases involve the misfolding of the cellular prion protein (PrP(c)) into the disease-associated scrapie form (PrP(Sc)).
- Scrapie-associated fibrils (SAFs) are key pathological hallmarks, with PrP(Sc) being a major component.
- The exact mechanism of prion transmission and the role of cofactors remain under investigation.
Purpose of the Study:
- To review experimental evidence on the interaction between nucleic acids (NAs) and PrP.
- To elucidate the role of NAs in the structural transformation of PrP(c) to PrP(Sc).
- To propose an updated hypothesis on the function of NAs in prion disease pathogenesis.
Main Methods:
- Literature review of experimental studies on PrP-NA interactions.
- Analysis of structural and biochemical alterations in PrP induced by NAs.
- Hypothesis formulation based on experimental findings.
Main Results:
- Nucleic acids (NAs) induce structural and biochemical changes in PrP(c), mimicking PrP(Sc) characteristics.
- Evidence suggests NAs interact with PrP, influencing its conformation.
- The presence of NAs is linked to the PrP(c) to PrP(Sc) conversion process.
Conclusions:
- Nucleic acids (NAs) likely act as catalysts or chaperones in the PrP(c) --> PrP(Sc) transformation.
- NAs do not encode genetic information but facilitate the conformational change of PrP.
- This interaction is a critical factor in prion disease transmission and progression.